We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current TKBIF market cap is 2.79B. The company's latest EPS is JPY 12.2908 and P/E is 1.89.
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Revenue | 34.57B | 46.09B | 67.7B | 78.14B | 43.51B |
| Operating Income | 5.4B | 13.95B | 28.73B | 20.54B | 2.8B |
| Net Income | 3.82B | 9.55B | 19.85B | 16.01B | 1.48B |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Assets | 75.01B | 89.75B | 115.71B | 129.2B | 121.25B |
| Total Liabilities | 8.42B | 15.45B | 19.65B | 16.75B | 9.47B |
| Total Equity | 66.59B | 74.3B | 96.07B | 112.46B | 111.79B |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Operating | 6.34B | 13.94B | 6.99B | 36.9B | 1.71B |
| Investing | -212M | -3.78B | -7.07B | -6.69B | -13.04B |
| Financing | -947M | -1.1B | -2.07B | -4.12B | -5.23B |
| Market Cap | 2.79B |
| Price to Earnings Ratio | 1.89 |
| Price to Sales Ratio | 0.06 |
| Price to Cash Ratio | 0.08 |
| Price to Book Ratio | 0.02 |
| Dividend Yield | - |
| Shares Outstanding | 120.42M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 23.20 |
| 52 Week Low | 23.20 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Takara Bio Inc (PK) |
| Address |
7-4-38 nojihigashi kusatsu, shiga 525-005 |
| Website | https://www.takara-bio.co.jp |
| Industry | chemicals diversified (B1) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
